2H-1-Benzazepin-2-one, 7-[2-[(1,6-dihydro-6-oxo-4-propyl-2-pyrimidinyl)thio]acetyl]-1,3,4,5-tetrahydro-

Request For Quotation
2H-1-Benzazepin-2-one, 7-[2-[(1,6-dihydro-6-oxo-4-propyl-2-pyrimidinyl)thio]acetyl]-1,3,4,5-tetrahydro- Suppliers list
Company Name: Tianjin Kailiqi Biotechnology Co., Ltd.  
Tel: 15076683720
Email: klq@cw-bio.com
Company Name: ShangHai ChuanQian Chemcial Technique Centre  
Tel: 15869524721
Email: 3525679403@qq.com
Company Name: Shanghai Yifei Biotechnology Co. , Ltd.  
Tel: 021-65675885 18964387627
Email: customer_service@efebio.com
Company Name: TargetMol Chemicals Inc.  
Tel: 15002134094
Email: marketing@targetmol.cn
Company Name: Shanghai Amole Biotechnology Co., Ltd.  
Tel: 13370042665 18916960931
Email: 2596183085@qq.com

2H-1-Benzazepin-2-one, 7-[2-[(1,6-dihydro-6-oxo-4-propyl-2-pyrimidinyl)thio]acetyl]-1,3,4,5-tetrahydro- manufacturers

  • S07-2010
  • S07-2010 pictures
  • $52.00
  • 2026-07-31
  • CAS:1223194-71-5
  • Purity: 98.13%
  • Supply Ability: 10g
2H-1-Benzazepin-2-one, 7-[2-[(1,6-dihydro-6-oxo-4-propyl-2-pyrimidinyl)thio]acetyl]-1,3,4,5-tetrahydro- Basic information
Product Name:2H-1-Benzazepin-2-one, 7-[2-[(1,6-dihydro-6-oxo-4-propyl-2-pyrimidinyl)thio]acetyl]-1,3,4,5-tetrahydro-
Synonyms:2H-1-Benzazepin-2-one, 7-[2-[(1,6-dihydro-6-oxo-4-propyl-2-pyrimidinyl)thio]acetyl]-1,3,4,5-tetrahydro-;S07-2010
CAS:1223194-71-5
MF:C19H21N3O3S
MW:371.45
EINECS:
Product Categories:
Mol File:1223194-71-5.mol
2H-1-Benzazepin-2-one, 7-[2-[(1,6-dihydro-6-oxo-4-propyl-2-pyrimidinyl)thio]acetyl]-1,3,4,5-tetrahydro- Structure
2H-1-Benzazepin-2-one, 7-[2-[(1,6-dihydro-6-oxo-4-propyl-2-pyrimidinyl)thio]acetyl]-1,3,4,5-tetrahydro- Chemical Properties
density 1.36±0.1 g/cm3(Predicted)
pka7.71±0.50(Predicted)
form Solid
color White to off-white
Safety Information
MSDS Information
2H-1-Benzazepin-2-one, 7-[2-[(1,6-dihydro-6-oxo-4-propyl-2-pyrimidinyl)thio]acetyl]-1,3,4,5-tetrahydro- Usage And Synthesis
DescriptionS07-2010 is an AKR1C3 inhibitor. S07-2010 may serve as promising therapeutic adjuvants toward new therapeutics for countering drug resistance.
UsesS07-2010 is a potent pan-AKR1C (aldo-keto reductase family 1 member C) inhibitor, with IC50 values of 0.19, 0.36, 0.47, and 0.73 μM for AKR1C3, AKR1C4, AKR1C1 and AKR1C2, respectively. S07-2010 induces apoptosis in A549/DDP cells. S07-2010 strengthens the cytotoxicity of chemotherapeutic agents in drug-resistant cells. S07-2010 significantly inhibits the proliferation of drug-resistant cells[1].
References[1] Siyu He, et al. Discovery of Novel Aldo-Keto Reductase 1C3 Inhibitors as Chemotherapeutic Potentiators for Cancer Drug Resistance. ACS Med. Chem. Lett. 2022.
2H-1-Benzazepin-2-one, 7-[2-[(1,6-dihydro-6-oxo-4-propyl-2-pyrimidinyl)thio]acetyl]-1,3,4,5-tetrahydro- Preparation Products And Raw materials
Tag:2H-1-Benzazepin-2-one, 7-[2-[(1,6-dihydro-6-oxo-4-propyl-2-pyrimidinyl)thio]acetyl]-1,3,4,5-tetrahydro-(1223194-71-5) Related Product Information
NA N-[4-[2-[(6-methyl-4-oxo-1H-pyrimidin-2-yl)sulfanyl]acetyl]phenyl]acetamide 2H-1-Benzazepin-2-one, 7-[2-[(1,6-dihydro-6-oxo-4-propyl-2-pyrimidinyl)thio]acetyl]-1,3,4,5-tetrahydro- 2-phenacylsulfanyl-6-propyl-1H-pyrimidin-4-one 4(3H)-Pyrimidinone, 2-[[2-(4-methoxyphenyl)-2-oxoethyl]thio]-6-propyl- quercetin 3-O-gentobioside